268 related articles for article (PubMed ID: 20067875)
1. Proniosomes as drug carriers.
Sankar V; Ruckmani K; Durga S; Jailani S
Pak J Pharm Sci; 2010 Jan; 23(1):103-7. PubMed ID: 20067875
[TBL] [Abstract][Full Text] [Related]
2. A review on novel vesicular drug delivery: proniosomes.
Yasam VR; Jakki SL; Natarajan J; Kuppusamy G
Drug Deliv; 2014 Jun; 21(4):243-9. PubMed ID: 24128089
[TBL] [Abstract][Full Text] [Related]
3. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
[TBL] [Abstract][Full Text] [Related]
4. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
Mokhtar M; Sammour OA; Hammad MA; Megrab NA
Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.
Alsarra IA
J Microencapsul; 2009 May; 26(3):272-8. PubMed ID: 18720197
[TBL] [Abstract][Full Text] [Related]
6. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation.
Aggarwal D; Garg A; Kaur IP
J Pharm Pharmacol; 2004 Dec; 56(12):1509-17. PubMed ID: 15563757
[TBL] [Abstract][Full Text] [Related]
7. Proniosomal powder of captopril: formulation and evaluation.
Gupta A; Prajapati SK; Singh M; Balamurugan M
Mol Pharm; 2007; 4(4):596-9. PubMed ID: 17472398
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
Guinedi AS; Mortada ND; Mansour S; Hathout RM
Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
[TBL] [Abstract][Full Text] [Related]
9. Technology overview and drug delivery application of proniosome.
Ahmad MZ; Mohammed AA; Mokhtar Ibrahim M
Pharm Dev Technol; 2017 May; 22(3):302-311. PubMed ID: 26794727
[TBL] [Abstract][Full Text] [Related]
10. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium.
Abd-Elbary A; El-laithy HM; Tadros MI
Int J Pharm; 2008 Jun; 357(1-2):189-98. PubMed ID: 18339494
[TBL] [Abstract][Full Text] [Related]
11. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
[TBL] [Abstract][Full Text] [Related]
12. Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.
Song S; Tian B; Chen F; Zhang W; Pan Y; Zhang Q; Yang X; Pan W
Drug Dev Ind Pharm; 2015 Jan; 41(1):51-62. PubMed ID: 24111828
[TBL] [Abstract][Full Text] [Related]
13. Prolonged release biodegradable vesicular carriers for rifampicin--formulation and kinetics of release.
Kamath MP; Shenoy BD; Tiwari SB; Karki R; Udupa N; Kotian M
Indian J Exp Biol; 2000 Feb; 38(2):113-8. PubMed ID: 11218826
[TBL] [Abstract][Full Text] [Related]
14. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies.
El-Laithy HM; Shoukry O; Mahran LG
Eur J Pharm Biopharm; 2011 Jan; 77(1):43-55. PubMed ID: 21056658
[TBL] [Abstract][Full Text] [Related]
15. Proniosomes derived niosomes: recent advancements in drug delivery and targeting.
Khatoon M; Shah KU; Din FU; Shah SU; Rehman AU; Dilawar N; Khan AN
Drug Deliv; 2017; 24(sup1):56-69. PubMed ID: 29130758
[TBL] [Abstract][Full Text] [Related]
16. Niosomes in sustained and targeted drug delivery: some recent advances.
Azeem A; Anwer MK; Talegaonkar S
J Drug Target; 2009 Nov; 17(9):671-89. PubMed ID: 19845484
[TBL] [Abstract][Full Text] [Related]
17. Proniosomes in transdermal drug delivery.
Rahimpour Y; Kouhsoltani M; Hamishehkar H
Curr Pharm Des; 2015; 21(20):2883-91. PubMed ID: 25925111
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of a proniosome hydrocortisone gel in comparison with a commercial cream.
Sankar V; Praveen C; Prasanth KG; Srinivas CR; Ruckmann K
Pharmazie; 2009 Nov; 64(11):731-4. PubMed ID: 20099517
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of proniosomes containing lornoxicam.
Madan JR; Ghuge NP; Dua K
Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]